TY - JOUR
T1 - Evidence-based medicine has already adapted and is very much alive
AU - Murad, Mohammad Hassan
AU - Saadi, Samer
N1 - Publisher Copyright:
©
PY - 2022/7/19
Y1 - 2022/7/19
N2 - Greenhalgh et al 1 argue that the COVID-19 pandemic has uncovered a need for a shift in the evidence-based medicine (EBM) paradigm in which mechanistic evidence is also used as a complementary source for decision-making. Their justification is based on limitations of evidence hierarchies, which prioritise meta-analyses and randomised controlled trials (RCTs)1; and the urgency, threat and complexity of a pandemic. However, in defence of EBM, we present a counter argument.
AB - Greenhalgh et al 1 argue that the COVID-19 pandemic has uncovered a need for a shift in the evidence-based medicine (EBM) paradigm in which mechanistic evidence is also used as a complementary source for decision-making. Their justification is based on limitations of evidence hierarchies, which prioritise meta-analyses and randomised controlled trials (RCTs)1; and the urgency, threat and complexity of a pandemic. However, in defence of EBM, we present a counter argument.
KW - Clinical Decision-Making
KW - Evidence-Based Practice
UR - http://www.scopus.com/inward/record.url?scp=85134775398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134775398&partnerID=8YFLogxK
U2 - 10.1136/bmjebm-2022-112046
DO - 10.1136/bmjebm-2022-112046
M3 - Review article
C2 - 35853684
AN - SCOPUS:85134775398
SN - 2515-446X
VL - 27
SP - 261
EP - 262
JO - BMJ evidence-based medicine
JF - BMJ evidence-based medicine
IS - 5
ER -